Core Viewpoint - The plan aims to establish Pinggu District as a leading domestic hub for the alternative protein industry, targeting a scale of 100 billion yuan by 2027 [1] Group 1: Strategic Directions - The plan focuses on five strategic directions: breakthrough key technologies, platform empowerment for results transformation, scenario-driven demonstration promotion, nurturing emerging industries, and collaborative regional development [2] - It outlines 14 key tasks across four major areas, with the goal of creating a nationally leading innovation application hub for alternative proteins by 2027 [2] Group 2: Technological Development - The plan emphasizes core technology research, particularly in frontier areas such as plant protein, microbial protein, and cell-cultured protein [2] - It supports technology companies in collaboration with domestic and international universities and research institutions to create comprehensive innovation platforms that integrate R&D, incubation, and transformation [2] Group 3: Industry Structure - The plan establishes a "3+X" industry cultivation system, focusing on the development of plant-based meat and dairy alternatives, addressing specific consumer needs such as allergies and youth nutrition [2] - It aims to overcome key technological bottlenecks in microbial protein production, particularly in filamentous fungi, to facilitate the transition from lab research to industrial-scale production [2] - The cell-cultured protein sector will focus on foundational technology research to achieve breakthroughs in efficient cell proliferation and differentiation [2] Group 4: Additional Directions - The plan encourages exploration of other development directions such as insect protein and synthetic protein, promoting innovation applications in animal feed and functional foods [3] - To ensure successful implementation of the plan, Pinggu District plans to establish high-level public service platforms for alternative protein bio-manufacturing [3]

新京报讯(记者曹晶瑞)近日，平谷区与北京市发改委联合印发了《北京市平谷区加快替代蛋白产业创新 发展行动计划(2025-2027年)》(以下简称《计划》)。该《计划》作为全市首个绿色经济领域出台的区级 落实方案，旨在将平谷区打造成为国内领先的千亿级替代蛋白产业集群。 据介绍，平谷区将依托其农业中关村的科技优势以及替代蛋白产业联盟的协同效应，全力构建从"研发- 转化-产业-生态"的全链条发展体系。在核心技术攻关方面，借助国家农业科技创新港等国家级平台资 源，重点围绕植物蛋白、微生物蛋白及细胞培育蛋白等前沿领域，开展关键核心技术的深度攻关。支持 科技型企业联合国内外高校与科研机构，共同打造集"研发-孵化-转化"功能于一体的综合性创新平台， 促进科研成果的高效转化与市场化应用。 在产业体系构建层面，系统构建"3+X"的产业培育体系，夯实产业发展根基。"植物蛋白产业"将聚焦植 物基肉类及奶类替代品的技术升级与规模化生产，针对过敏人群、青少年等特定消费群体的个性化需 求，开发营养新产品。"微生物蛋白产业"将致力于攻克丝状真菌等生物制造领域的关键核心技术瓶颈， 打通从实验室研发到工业化规模生产的技术路径。"细胞培育蛋白产业 ...

日前，韩国出台了全球首个合成生物法，而正在此时，韩国一家替代蛋白质初创公司传来重大融资消息。 INTAKE 利用当地种植的葡萄开发了一种 酵母菌株 ，其蛋白质含量比传统酵母高 1.5 倍 ，旨在取代 乳清蛋白 。该菌株通过适应性进化，并非转基因产 品，因此不受重大监管限制。尽管如此，Intake 正在准备所有必要的数据，以获得美国食品药品监督管理局的 NDI（新膳食成分）和 GRAS认证，确保不存 在任何安全问题。 此外，Intake 正在利用基于 CRISPR 的基因编辑技术，在原生菌株中表达，研发血红素蛋白——一种已知赋予牛肉红色和肉味的主要成分。植物肉巨头 Impossible Foods 也利用精准发酵技术，为其牛肉类似物生产血红素蛋白。 该公司还在利用该技术开发 蛋清蛋白 。加州的 Every Company 和芬兰的 Onego Bio 是这一领域的领导者，前者销售重组鸡蛋蛋白已有数年，后者最近获准 在美国销售其成分。 Intake 现有的业务包括补水品牌 Vital Water，去年为公司带来了 1520 万美元的净收入，年增长率达 30%。Innocent 品牌旗下销售素食饺子、肉丸、沙拉三 ...